Cat. No. | Product name | CAS No. |
DC8266 |
GW-627368X
Featured
GW 627368X is a selective prostanoid EP4 receptor competitive antagonist with additional affinity at TP receptors (pKi values are 7.0 and 6.8 in competition radioligand bioassays). |
439288-66-1 |
DC2078 |
GW-7647
Featured
GW 7647 is a potent PPARα agonist with 200-fold selectivity over PPARγ and PPARδ. |
265129-71-3 |
DC9904 |
GW0742
Featured
GW-0742 is a potent and highly selective PPARδ agonist. |
317318-84-6 |
DC7149 |
GW1929
Featured
GW1929 is a synthetic peroxisome proliferator-activated receptor-γ (PPARγ) agonist with IC50 of 6.2 nM and 13 nM for human and mouse, respectively. |
196808-24-9 |
DC1018 |
GW-2580 (GW2580)
Featured
GW2580 is a selective inhibitor of human c-FMS with IC50 of 30 nM. |
870483-87-7 |
DC23142 |
GW274150
Featured
GW274150 is a novel arginine-competitive, NADPH-dependent iNOS inhibitor that has been identified from a series of acetamide amino acids that have a high selectivity for iNOS vs both eNOS (> 260-fold) and nNOS (> 219-fold) and high bioavailability (> 90%) after oral administration.Target: iNOSin vivo: GW274150 demonstrates a narrow neuroprotective therapeutic window against the toxic actions of 6-OHDA. GW274150 administration leads to a dose-dependent decrease in the number of iNOS-positive cells in the SNc of the 6-OHDA-lesioned animals. The iNOS inhibitor GW274150 fails to produce long-term neuroprotection after its withdrawal in the 6-OHDA-lesioned rat. [1] |
210354-22-6 |
DC7837 |
GW-3965 hydrochloride
Featured
GW3965 HCl is a potent, selective LXR agonist for hLXRα and hLXRβ with EC50 of 190 and 30 nM, respectively. |
405911-17-3 |
DC7662 |
GW4869
Featured
GW4869 is a cell permeable, selective inhibitor of N-SMase (neutral sphingomyelinase). |
6823-69-4 |
DC4233 |
GW501516
Featured
GW501516 is the most selective and potent PPARβ (EC50=1.1nM) agonist that has been demonstrated to be 1,000-fold more selective in comparison to existing subtypes. |
317318-70-0 |
DC7980 |
GW-6604
Featured
GW6604 is a potent and selective ALK-5 inhibitor with potent anticancer activity. |
452342-37-9 |
DC7146 |
GW788388
Featured
GW788388 is a potent and selective inhibitor of ALK5 with IC50 of 18 nM, also inhibits TGF-β type II receptor and activin type II receptor activities, but does not inhibit BMP type II receptor. |
452342-67-5 |
DC10503 |
GW806742X
Featured
GW806742X is a novel VEGFR inhibitor. |
579515-63-2 |
DC8609 |
GW843682X
Featured
GW843682X is a cell-permeable thiophene-benzimidazole compound and reversible PLK inhibitor |
660868-91-7 |
DC22653 |
GW-8510
Featured
GW-8510 (GW8510) is a potent, selective inhibitor of CDK2 with IC50 of 10 nM. |
222036-17-1 |
DC1086 |
GW-9508
Featured
GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32. |
885101-89-3 |
DC2079 |
GW-9662
Featured
GW9662 is a selective PPAR antagonist, inhibiting PPARγ, PPARα and PPARδ with IC50 of 3.3 nM, 32 nM and 2 μM, respectively. |
22978-25-2 |
DC26080 |
GX-674
Featured
GX-674 is a potent, selective Nav1.7 inhibitor with IC50 of 0.1 nM. |
1432913-36-4 |
DC10668 |
GYY4137 morpholine salt
Featured
GYY 4137 is a Water-soluble, slow-releasing hydrogen sulfide donor. |
106740-09-4 |
DC7147 |
GZD824
Featured
GZD824 is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively. |
1257628-77-5 |
DC7835 |
H-89 2HCl
Featured
H 89 2HCl is a potent PKA inhibitor with Ki of 48 nM, 10-fold selective for PKA than PKG, greater than 500-fold selectivity than PKC, MLCK, calmodulin kinase II and casein kinase I/II. |
130964-39-5 |
DC10876 |
H-151
Featured
H-151(H151) is a novel STING (stimulator of interferon genes) antagonist. |
941987-60-6 |
DC10033 |
H3B-6527
Featured
H3B-6527 is an orally bioavailable inhibitor of human fibroblast growth factor receptor 4 (FGFR4), with potential antineoplastic activity. |
1702259-66-2 |